What are new treatment options for newly-diagnosed multiple myeloma patients? Dr. Paul G. Richardson Dana-Farber Cancer Institute 44:05 5 years ago 4 903 Скачать Далее
Dr. Paul G. Richardson Provides Study Updates on the Phase 3 DETERMINATION Trial for NDMM patients International Myeloma Foundation 17:24 2 years ago 1 484 Скачать Далее
Paul G. Richardson, MD, shares clinical results from the ECOG trial in smoldering MM OBRoncology 2:21 5 years ago 20 Скачать Далее
Paul G. Richardson, MD, considers progression-free survival in MM when treating with isatuximab OBRoncology 2:32 5 years ago 82 Скачать Далее
Paul G. Richardson, MD, regarding the updated FORTE trial data in multiple myeloma OBRoncology 3:48 5 years ago 29 Скачать Далее
Dr. Paul Richardson on novel approaches for treating multiple myeloma | Dana-Farber Cancer Institute Dana-Farber Cancer Institute 35:50 6 years ago 5 196 Скачать Далее
Paul G. Richardson, MD, considers whether isatuximab shows promise as a treatment option for MM OBRoncology 1:28 5 years ago 46 Скачать Далее
The status quo is not enough: Dr. Paul Richardson | Dana-Farber Cancer Institute Dana-Farber Cancer Institute 1:37 12 years ago 5 999 Скачать Далее
Multiple myeloma mid-year progress with Dr. Paul Richardson of Dana Farber HealthTree Foundation for Multiple Myeloma 1:04:18 4 months ago 96 Скачать Далее
Myeloma Determination Study | Paul Richardson, MD | IMS 2022 HealthTree Foundation for Multiple Myeloma 7:32 1 year ago 1 267 Скачать Далее
Dr. Richardson on First-In-Human Phase 1 Trial With CC-92480 in R/R Myeloma OncLive 1:36 4 years ago 90 Скачать Далее
Dr. Richardson on the Mechanism of Action of CC-92480 in Multiple Myeloma OncLive 1:52 4 years ago 290 Скачать Далее
ASCO 2019: Isatuximab ICARIA-MM Trial Updates with Dr. Paul Richardson HealthTree Foundation for Multiple Myeloma 5:11 5 years ago 492 Скачать Далее
Treatment Options For Frail Patients at Early Relapse | Paul Richardson, MD | IMS 2023 HealthTree Foundation for Multiple Myeloma 7:26 10 months ago 284 Скачать Далее
Mezigdomide (CC-92480) | Paul Richardson, MD | ASH 2022 HealthTree Foundation for Multiple Myeloma 8:06 1 year ago 324 Скачать Далее
Paul Richardson, MD Shares a Review of the IMW Boston Conference - IMW 2019 HealthTree Foundation for Multiple Myeloma 7:32 4 years ago 392 Скачать Далее
CELMoDs® Mezigdomide | Paul Richardson, MD | IMS 2022 HealthTree Foundation for Multiple Myeloma 1:51 1 year ago 317 Скачать Далее
Dr. Richardson on Isatuximab Triplet Regimen in Relapsed/Refractory Myeloma OncLive 2:55 5 years ago 227 Скачать Далее
mPatient Myeloma Radio: Dr. Paul Richardson, MD, Dana-Farber Cancer Institute HealthTree Foundation for Multiple Myeloma 1:28:28 4 months ago 17 Скачать Далее
